.

0 (hodnocen0 x )

EB

ONLINE

1st ed.

Sharjah : Bentham Science Publishers, 2021

1 online resource (223 pages)

ISBN 9781681088082 (electronic bk.)

ISBN 9781681088099

Print version: Mittal, Neeraj COVID-19: Diagnosis and Management - Part I Sharjah : Bentham Science Publishers,c2021 ISBN 9781681088099

Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Chapter 1 -- Sunishtha1, Govind Singh1 and Sanju Nanda1,* -- INTRODUCTION -- THE ATHENIAN PLAGUE -- PLAGUE OF JUSTINIAN -- THE BLACK DEATH -- SPANISH FLU -- AIDS -- SMALLPOX -- SARS -- SWINE FLU OR H1N1 PANDEMIC -- EBOLA -- COVID-19 -- ORIGIN OF CORONAVIRUS -- TYPES OF CORONAVIRUSES -- DISEASE ASSOCIATED WITH CORONAVIRUSES -- MURINE HEPATITIS VIRUS (MHV) -- Central Nervous System -- Hepatitis -- Pneumonitis -- BOVINE CORONAVIRUS -- HUMAN CORONAVIRUS -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 2 -- Hitesh Malhotra1,*, Anjoo Kamboj1 and Peeyush Kaushik1 -- INTRODUCTION -- GENOMIC STRUCTURE OF CORONAVIRUS -- STRUCTURAL PROTEINS -- Spike Protein -- Small Membrane Protein -- Membrane Protein -- Hemagglutinin-Esterase -- Nucleocapsid and Internal Proteins -- Replicase Protein -- VIRAL CYCLE -- OUTBREAKS OF CORONAVIRUS -- Porcine Coronavirus -- Avian Coronavirus -- Feline Coronavirus -- Bovine Coronavirus -- Murine Coronavirus -- Human Coronavirus -- SARS-CoV -- MERS-CoV -- COVID-19 -- Introduction -- Chronology of COVID-19 -- Symptoms -- Transmission -- Treatment -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 3 -- Kamya Goyal1,2,#, Shammy Jindal1,#, Tarun Kumar3, Jugnu Goyal4, Reena Sharma5, Ravinder Singh6 and Samir Mehndiratta7,8,* -- INTRODUCTION -- GEOGRAPHICAL DISTRIBUTION -- GLOBAL EPIDEMIOLOGY OF COVID-19 -- Effect of Age, Sex and other Factors on Covid-19-Related Deaths -- COVID-19 CASE COMPARISONS IN DIFFERENT REGION OF WORLD (WORLD HEALTH ORGANIZATION, 2020) -- COVID-19 IN INDIA -- REPORT BY ICMR ON COVID-19 ABOUT CONTAINMENT ZONE IN INDIA -- NATIONAL RESPONSES ON COVID-19 WORLDWIDE.

Asia -- China -- South Korea -- Middle Eastern -- Iran -- Europe -- Spain -- France -- North America -- United States -- South America -- Africa -- Oceania -- EFFECT OF LOCKDOWN ON COVID-19 CASES IN TOP TEN MOST AFFECTED COUNTRIES OF WORLD -- THE ROLE OF WHO AND INGOS FOR PROVIDING DATA IN COVID-19 -- OUTCOMES FROM SOME PUBLISHED REPORTS ON COVID-19 EPIDEMIOLOGY -- Herd Immunity-COVID-19 -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 4 -- Anirban Ghosh1 and Shamsher Singh1,* -- INTRODUCTION -- TRANSMISSION OF COV -- Virus Life Cycle -- Role of Structural Proteins in The Pathogenesis -- A. Spike Protein -- B. Hemagglutinin-Esterase (HE) Protein -- C. Membrane (M) Protein -- D. Small Envelop (E) Protein -- E. Nucleocapsid (N) Protein and Internal (I) Protein -- F. Replicase Proteins -- G. CoV Associated Protein -- Pathophysiology from a Cell Biology Perspective -- Phase I. Asymptomatic Stage (First 1-2 Days of Infection) -- Phase II. Upper Airway and Conducting Airway Response (Next Few Days) -- Phase III. Hypoxia, Ground-glass Infiltrates, Progression to ARDs -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 5 -- Jasleen Kaur1, Baljinder Singh2, Bikash Medhi3 and Gurpreet Kaur1,* -- INTRODUCTION -- CLINICAL PRESENTATIONS OF COVID-19 INFECTION -- INTER-INDIVIDUAL VARIATIONS IN CLINICAL PRESENTATIONS DUE TO DIFFERENTIAL SUSCEPTIBILITY TOWARDS COVID-19 -- Neonates or Newborns (Upto 1 Month) -- Infants (1 Month-2 Years), Children (2-10 Years) -- Adolescent (11-19 Years), Young (20-35 Years) and Middle Aged (36-59 Years) Patients -- Elderly (&gt -- 60 Years) and Older (&gt -- 80 Years) Patients -- ACE2 -- Gender -- Blood Group -- Previous Immunization -- COMORBIDITY -- CONCLUSION.

Asia -- China -- South Korea -- Middle Eastern -- Iran -- Europe -- Spain -- France -- North America -- United States -- South America -- Africa -- Oceania -- EFFECT OF LOCKDOWN ON COVID-19 CASES IN TOP TEN MOST AFFECTED COUNTRIES OF WORLD -- THE ROLE OF WHO AND INGOS FOR PROVIDING DATA IN COVID-19 -- OUTCOMES FROM SOME PUBLISHED REPORTS ON COVID-19 EPIDEMIOLOGY -- Herd Immunity-COVID-19 -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 4 -- Anirban Ghosh1 and Shamsher Singh1,* -- INTRODUCTION -- TRANSMISSION OF COV -- Virus Life Cycle -- Role of Structural Proteins in The Pathogenesis -- A. Spike Protein -- B. Hemagglutinin-Esterase (HE) Protein -- C. Membrane (M) Protein -- D. Small Envelop (E) Protein -- E. Nucleocapsid (N) Protein and Internal (I) Protein -- F. Replicase Proteins -- G. CoV Associated Protein -- Pathophysiology from a Cell Biology Perspective -- Phase I. Asymptomatic Stage (First 1-2 Days of Infection) -- Phase II. Upper Airway and Conducting Airway Response (Next Few Days) -- Phase III. Hypoxia, Ground-glass Infiltrates, Progression to ARDs -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 5 -- Jasleen Kaur1, Baljinder Singh2, Bikash Medhi3 and Gurpreet Kaur1,* -- INTRODUCTION -- CLINICAL PRESENTATIONS OF COVID-19 INFECTION -- INTER-INDIVIDUAL VARIATIONS IN CLINICAL PRESENTATIONS DUE TO DIFFERENTIAL SUSCEPTIBILITY TOWARDS COVID-19 -- Neonates or Newborns (Upto 1 Month) -- Infants (1 Month-2 Years), Children (2-10 Years) -- Adolescent (11-19 Years), Young (20-35 Years) and Middle Aged (36-59 Years) Patients -- Elderly (> -- 60 Years) and Older (> -- 80 Years) Patients -- ACE2 -- Gender -- Blood Group -- Previous Immunization -- COMORBIDITY -- CONCLUSION.

LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 6 -- Richa Deshpande1,#, Aishwarya Joshi1,#, Nikunj Tandel1 and Rajeev K. Tyagi2,* -- COVID-19: A PANDEMIC DISEASE -- COVID-19: EARLY DETECTION BASED ON SYMPTOMS -- Clinical Analysis -- Hematological Analysis -- Chest CT -- COVID-19: MOLECULAR DETECTION OF VIRUS -- RT-PCR Based Assays -- Loop Mediated Isothermal Amplification (LAMP) -- CRISPR-Isothermal Amplification Based Assays -- Microarrays -- Metagenomic Sequencing Based Methods -- Gold Nanoparticles-Based Colorimetric Assay -- COVID-19: SERIOLOGICAL AND IMMUNOLOGICAL BASED DETECTION -- BIOMARKER IDENTIFICATION: APPROACH OF SEROLOGICAL PLATFORM -- Antibody Biomarkers -- Antigen Biomarkers -- Procalcitonin and Interleukin-6 as Prognostic COVID-19 Biomarkers -- SEROLOGICAL AND IMMUNOLOGICAL ASSAYS -- Enzyme-linked Immunosorbent Assay (ELISA) -- Lateral Flow Immunoassay -- Neutralization Assays -- Luminescence-based Immunoassays -- Biosensor Tests -- Rapid Antigen Tests -- CONCLUDING REMARKS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index.

001905067

express

(Au-PeEL)EBL6676570

(MiAaPQ)EBC6676570

(OCoLC)1260344220